Fabiola Cervantes-Gomez

Fabiola Cervantes-Gomez

UNVERIFIED PROFILE

Are you Fabiola Cervantes-Gomez?   Register this Author

Register author
Fabiola Cervantes-Gomez

Fabiola Cervantes-Gomez

Publications by authors named "Fabiola Cervantes-Gomez"

Are you Fabiola Cervantes-Gomez?   Register this Author

8Publications

116Reads

25Profile Views

PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cells.

Oncotarget 2019 Apr 19;10(29):2793-2809. Epub 2019 Apr 19.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26876DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497463PMC
April 2019

Combination of Pim kinase inhibitors and Bcl-2 antagonists in chronic lymphocytic leukemia cells.

Leuk Lymphoma 2016 Feb 28;57(2):436-444. Epub 2015 Sep 28.

a Department of Experimental Therapeutics , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1063141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814351PMC
February 2016

Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia.

Clin Cancer Res 2015 Aug 31;21(16):3705-15. Epub 2015 Mar 31.

Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, Texas. Department of Leukemia, MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2809DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537801PMC
August 2015

Proteasome inhibitor carfilzomib complements ibrutinib's action in chronic lymphocytic leukemia.

Blood 2015 Jan;125(2):407-10

Departments of Experimental Therapeutics and Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-07-585364DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287645PMC
January 2015

Biological effects of the Pim kinase inhibitor, SGI-1776, in multiple myeloma.

Clin Lymphoma Myeloma Leuk 2013 Sep 27;13 Suppl 2:S317-29. Epub 2013 Aug 27.

Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.05.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951475PMC
September 2013

ATP analog enhances the actions of a heat shock protein 90 inhibitor in multiple myeloma cells.

J Pharmacol Exp Ther 2011 Nov 5;339(2):545-54. Epub 2011 Aug 5.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.111.184903DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199983PMC
November 2011

Transcription inhibition of heat shock proteins: a strategy for combination of 17-allylamino-17-demethoxygeldanamycin and actinomycin d.

Cancer Res 2009 May 21;69(9):3947-54. Epub 2009 Apr 21.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-08-4406DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778753PMC
May 2009

Multiple myeloma cell killing by depletion of the MET receptor tyrosine kinase.

Cancer Res 2007 Oct;67(20):9913-20

Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, and Graduate School of Biomedical Sciences, University of Texas Health Science Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-0770DOI Listing
October 2007